FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Horowitz Bruce		 2. Date of Event Requiring Statement (MM/DD/YYYY)
4/3/2017 

 3. Issuer Name and Ticker or Trading Symbol

PROVECTUS BIOPHARMACEUTICALS, INC. [PVCT]
(Last)        (First)        (Middle)

10025 INVESTMENT DRIVE, SUITE 250		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

KNOXVILLE, TN 37932      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
4/13/2017 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1827243 (1)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1) This amendment is being filed to report 435,000 shares of common stock held by the reporting person that were inadvertently omitted from his Form 3.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Horowitz Bruce
10025 INVESTMENT DRIVE
SUITE 250
KNOXVILLE, TN 37932		X
Signatures
/s/ Bruce Horowitz11/25/2020
**Signature of Reporting PersonDate
Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Provectus Biopharmaceuti... (QB).
Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Provectus Biopharmaceuti... (QB).